Ardeparin sodium

Ardeparin sodium

Ardeparin sodium

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity:
  • Payment Terms : L/C|D/A|D/P|T/T|Westem Union

Keywords

Quick Details

  • Appearance:White or almost white,hygroscopic powder.
  • Application:Used to slow down and prevent blood clots
  • PackAge:25kg/drum
  • ProductionCapacity:|/
  • Storage:cool and dry
  • Transportation:by sea ,air or express

Superiority:

Appearance: White or almost white,hygroscopic powder. Identification: A:Delay of clotting of recalcified citrated sheep plasma. …

Details:

 Appearance: White or almost white,hygroscopic powder. 

Identification:
A:Delay of clotting of recalcified citrated sheep plasma.
B:H-NMR Spectrum:conforms with EP specification of
heparin about H-NMR requirements.
C: The principal peak in the chromatogram obtained
with test solution is similar in retention time and shape to
the principal peak in the chromatogram obtained with
reference solution.
D:Positive sodium reaction.
Appearance of solution:
A: 5% w/v solution is clear and colourless.
B: Solution is not more intensely coloured than reference
solution BY5 or better.
PH :5.5~ 8.0 
Nucleotide impurities:
0.4% aqueous solution w/v
260nm:max 0.15
260nm: 0.05
Protein :≤ 0.5%(dried substance) 
Related substance:
Sum of dermatan sulfate and chondroitin sulfate:≤ 2.0%
Any other impurity: Free
Nitrogen: 1.5%~2.5%(dried substance) 
Sodium: 9.5%~12.5%(dried substance) 
Heavy metals: ≤ 30ppm 
Loss on drying :≤8.0% 
Bacterial endotoxins: ≤ 0.01 IU/IU of heparin 
Microbial contamination:
A: Bacteria:≤ 10CFU/g
B:Mold and yeast: ≤ 10CFU/g
C: Specified micro organisms
Escherichia coli

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View